gMG

8 registered clinical trials studyying gMG — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravu NCT07221838	Alexion Pharmaceuticals, Inc.	Phase 4
Recruiting	ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens i NCT07294170	argenx	—
Recruiting	ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Particip NCT07284420	argenx	Phase 2
Recruiting	PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Grav NCT06607627	Alexion Pharmaceuticals, Inc.	Phase 3
Active Not Recruiting	A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor NCT06298552	argenx	Phase 3
Active Not Recruiting	Evaluation of PK, PD, Efficacy, Safety, and Immunogenicity of IV Ravulizumab in Pediatric Participants With Ge NCT05644561	Alexion Pharmaceuticals, Inc.	Phase 3
Enrolling By Invitation	Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subc NCT05374590	argenx	Phase 2 / Phase 3
Completed	An Open-label Study to Investigate the Clinical Efficacy of Different Dosing Regimens of Efgartigimod IV in Pa NCT04980495	argenx	Phase 3